CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 248 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,823 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- CT ORDER Other Confidential Order
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Open-market sale Principal Accounting Officer sold 1,777 shares at $61.61 ($109,481)
- 4 Open-market sale Chief Medical Officer sold 48,493 shares at $60.11 ($2,914,851)
- 4 Open-market sale Chief Medical Officer sold 2,502 shares at $60.02 ($150,170)
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 28,002 shares at an average $60.09 ($1,682,554)
- 8-K Event Other events
- 4 Open-market sale Chief Medical Officer sold 10,943 shares at an average $60.05 ($657,171)
- 4 Option exercise Director acquired 1,686 shares (option exercise)
Page 24 of 66 · 1,304 filings